Clinical Trials Logo

Leukoplakia, Oral clinical trials

View clinical trials related to Leukoplakia, Oral.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05505539 Withdrawn - Oral Leukoplakia Clinical Trials

Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia

OL_5FU
Start date: September 30, 2022
Phase: Phase 1
Study type: Interventional

This is a single center, open-label, interventional pilot study to assess the feasibility, safety, and preliminary efficacy of intralesional 5-FU injections for the treatment of oral leukoplakia (OL).

NCT ID: NCT03939364 Withdrawn - Leukoplakia, Oral Clinical Trials

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Start date: January 2022
Phase: Phase 1
Study type: Interventional

This study will be the first study investigating the safety, pharmacokinetics (PK), and efficacy of SBS-101 on oral pre-malignant lesions. As such, no clinical data has yet been generated using SBS-101 oral adhesive film.